Transdermal clonidine.
Noerr
B
B
D000279:Administration, Cutaneous; D000700:Analgesics / Q000008:administration & dosage* / Q000009:adverse effects; D003000:Clonidine / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D007363:Intensive Care Units, Neonatal; D015931:Intensive Care, Neonatal / Q000379:methods; D008297:Male; D017283:Neonatal Nursing; D010146:Pain / Q000188:drug therapy*; D018570:Risk Assessment; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control
D000700:Analgesics; D003000:Clonidine